Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction

Pharmacogenetics and Genomics

Volumn 16, Issue 11, 2006, Pages 775-781

  Sata, Fumihiro ^a   Yamada, Hideto ^a   Suzuki, Kana ^a   Saijo, Yasuaki ^a   Yamada, Takashi ^a   Minakami, Hisanori ^a   Kishi, Reiko ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Catechol O methyltransferase; Genetic polymorphism; Intrauterine fetal growth restriction; Low birth weight

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 17;

ADULT; ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FETUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECESSIVE INHERITANCE;

ADOLESCENT; ADULT; BIRTH WEIGHT; CATECHOL O-METHYLTRANSFERASE; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 33750368070     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/01.fpc.0000230116.49452.c0     Document Type: Article

References (41)

1. Polani PE. Incidence of developmental and other genetic abnormalities. Proc R Soc Med 1973; 66:1118-1119.
2. Strauss RS. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. JAMA 2000; 283:625-632.
3. Lundgren EM, Cnattingius S, Jonsson B, Tuvemo T. Intellectual and psychological performance in males born small for gestational age with and without catch-up growth. Pediatr Res 2001; 50:91-96.
4. Gray PH, Jones P, O'Callaghan MJ. Maternal antecedents for cerebral palsy in extremely preterm infants: a case-control study. Dev Med Child Neurol 2001; 43:580-585.
5. Barker DJ. Fetal programming and public health. In: O'Brien PM, Wheeler T, Barker DJ, editors. Fetal programming: influences on development and disease in later life. London: RCOG Press; 1999. pp. 3-11.
6. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002; 287:195-202.
7. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002; 359:1036-1037.
8. Arends N, Johnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, Clark A. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab 2002; 87:2720-2724.
9. Yamada H, Sata F, Kato EH, Saijo Y, Kataoka S, Morikawa M, et al. A polymorphism in the CYP17 gene and intrauterine fetal growth restriction. Mol Hum Reprod 2004; 10:49-53.
10. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996; 36:203-232.
11. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998; 19:1-27.
12. Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-22q11.2. Genomics 1992; 12:822-825.
13. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250.
14. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer: characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993; 71:3036-3043.
15. Malins DC, Polissar NL, Gunselman SJ. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci USA 1996; 93:2557-2563.
16. Barnea ER. Modulatory effect of maternal serum on xenobiotic metabolizing activity of placental explants: modification by cigarette smoking. Hum Reprod 1994;9:1017-1021.
17. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, et al. High-throughput genotyping with single nucleotide polymorphisms. Genome Res 2001; 11:1262-1268.
18. Johnstone F, Inglis L. Familial trends in low birth weight. BMJ 1974; 3:659-661.
19. Khoury MJ, Calle EE, Joesoef RM. Recurrence of low birth weight in siblings. J Clin Epidemiol 1989; 42:1171-1178.
20. Hackman E, Emanuel I, van Belle G, Daling J. Maternal birth weight and subsequent pregnancy outcome. JAMA 1983; 250:2016-2019.
21. Klebanoff MA, Graubard BI, Kessel SS, Berendes HW. Low birth weight across generations. JAMA 1984; 252:2423-2427.
22. Klebanoff MA, Schulsinger C, Mednick BR, Secher NJ. Preterm and small-for-gestational-age birth across generations. Am J Obstet Gynecol 1997; 176:521-526.
23. Winkvist A, Mogren I, Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998; 27:248-254.
24. Yamada H, Sata F, Saijo Y, Kishi R, Minakami H. Genetic factors in fetal growth restriction and miscarriage. Semin Thromb Hemost 2005; 31:334-345.
25. Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum oestrogen and progesterone concentration. Cancer Res 1998; 58:585-587.
26. Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59:1015-1020.
27. Gorai I, Tanaka K, Inada M, Morinaga H, Uchiyama Y, Kikuchi R, et al. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab 2003; 88:799-803.
28. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997; 57:1063-1065.
29. Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 1999; 84:350-353.
30. Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2000; 92:1674-1681.
31. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997; 57:5493-5497.
32. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998; 58:2107-2110.
33. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999; 59:4870-4875.
34. Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, et al. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 2001; 11:279-286.
35. Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2003; 12:838-847.
36. Hamajima N, Matsuo K, Tajima K, Mizutani M, Iwata H, Iwase T, et al. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 2001; 6:13-18.
37. Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, et al. Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics 2002; 12:67-72.
38. Berg FD, Kuss E. Serum concentration and urinary excretion of 'classical' estrogens, catecholestrogens and 2-methoxyestrogens in normal human pregnancy. Arch Gynecol Obstet 1992; 251:17-27.
39. Scholl TO, Stein TP. Oxidant damage to DNA and pregnancy outcome. J Matern Fetal Med 2001; 10:182-185.
40. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303:1019-1022.
41. Luo ZC, Fraser WD, Julien P, Deal CL, Audibert F, Smith GN, et al. Tracing the origins of 'fetal origins' of adult diseases: programming by oxidative stress? Med Hypotheses 2006; 66:38-44.